Quotient Limited Ordinary Shares

Gainers Dermata Therapeutics, Inc. (NASDAQ: DRMA) shares jumped 121% to $0.4428 after the company requested to withdraw its registration on Form S-1 and said it does not intend to pursue the contemplated public offering. Palisade Bio, Inc. (NASDAQ: PALI) shares jumped 80.1% to $5.80. Palisade Bio announced $2.5 million registered direct offering and concurrent private placement priced above market under Nasdaq rules. Silo Pharma, Inc. (NASDAQ: SILO) gained 63.7% to $5.60 after the company announced study results of SPU-21 for arthritis. The company said SPU-21 is effective in controlling arthritis progression. F-star Therapeutics, Inc. (NASDAQ: FSTX) shares gained 42.8% to $5.84. F-Star Therapeutics shares traded lower on Thursday after the Committee on Foreign Investment issued an interim order preventing the closing of the pending merger with Invox Pharma. Kala Pharmaceuticals, Inc. (NASDAQ: KALA) jumped 38% to $33.65. Kala Pharmaceuticals recently announced FDA acceptance of an IND application for its KPI-012 for the treatment of persistent corneal epithelial defect. Charah Solutions, Inc. (NYSE: CHRA) gained 37.6% to $5.57. Charah Solutions reported receipt of notification letter from NYSE. Embark Technology, Inc. (NASDAQ: EMBK) gained 33% to $3.4686. NovaBay Pharmaceuticals, Inc. (NYSE: NBY) jumped 27.3% to $1.77. Allarity Therapeutics, Inc. (NASDAQ: ALLR) jumped 26.7% to $0.3679. Concord Medical Services Holdings Limited (NYSE: CCM) gained 23.8% to $1.6599. Mereo BioPharma Group plc (NASDAQ: MREO) surged 23.6% to $0.69. 9 Meters Biopharma, Inc. (NASDAQ: NMTR) gained 23% to $1.4450. Frequency Therapeutics, Inc. (NASDAQ: FREQ) jumped 22.5% to $3.97. Journey Medical Corporation (NASDAQ: DERM) surged 22% to $1.77. Journey Medical recently announced PK comparability data of DFD-29 and key updates on the progress of ...

Related tickers: HSTO, DERM, SILO, DS, FSTX, NBY, FUTU, ZEV, NILE, KALA, PALI, PTIX, SECO, TUEM, TIGR, RSLS, EZGO, RCI, BLNK, RNAZ, SJR, SRRK, UNCY, SCLX, RUBY, DRMA, CCM, SESN, SISI, NAVB, CHRA, ALLR, ECX, LEV, EMBK, SLRX, SXTC, NAAS, MREO, HOTH, GETR, AXDX, FREQ, KA, QTNT, NMTR.

Gainers Dermata Therapeutics, Inc. (NASDAQ: DRMA) shares rose 105% to $0.41 in pre-market trading after the company requested to withdraw its registration on Form S-1 and said it does not intend to pursue the contemplated public offering. Evaxion Biotech A/S (NASDAQ: EVAX) rose 34.4% to $2.38 in pre-market trading. Evaxion Biotech said on Dec 22, the FDA notified the company that it had reviewed the company's IND for Phase 2b clinical trial of EVX-01 in combination with Keytruda. Sesen Bio, Inc. (NASDAQ: SESN) shares rose 30.4% to $0.6590 in pre-market trading after the company and Carisma Therapeutics announced an increased special dividend of $70 million, or $0.34 per share, in connection with the pending merger. Tuesday Morning Corporation (NASDAQ: TUEM) rose 22.8% to $0.84 in pre-market trading after gaining around 16% on Thursday. Tuesday Morning recently announced it will voluntarily delist from the Nasdaq Capital Market. Landos Biopharma, Inc. (NASDAQ: LABP) rose 17.7% to $0.60 in pre-market trading after gaining 12% on Thursday. Palisade Bio, Inc. (NASDAQ: PALI) rose 17.1% to $3.77 in pre-market trading after jumping 78% on Thursday. Palisade Bio recently provided an update on its U.S. Phase ...

Related tickers: EVAX, DRMA, ARBK, NCMI, QNRX, SJR, PEGY, QTNT, ASAP, GMBL, GETR, RUBY, SESN, SXTC, HOTH, BXRX, PBLA, ZEV, LABP, PALI, TUEM.